Zenas BioPharma (ZBIO) Exchange Rate Effect (2023 - 2026)
Zenas BioPharma's (ZBIO) quarterly Exchange Rate Effect came in at -$311000.0 in Q1 2026, down 498.08% year-on-year from $78125.6 in Q1 2025, and down 2927.27% quarter-over-quarter from $11000.0 in Q4 2025.
Zenas BioPharma (ZBIO) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Zenas BioPharma's Exchange Rate Effect history runs 4 years deep, the most recent figure standing at -$311000.0 for Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 498.08% year-over-year to -$311000.0 in Q1 2026; TTM through Mar 2026 was -$511000.0, a 840.58% decrease from a year earlier, with the FY2025 full-year figure at -$252000.0, down 260.51% from the prior year.
- Exchange Rate Effect eased to -$311000.0 in Q1 2026 per ZBIO's latest filing, from $11000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $141000.0 in Q4 2024 and bottomed at -$311000.0 in Q1 2026.
- The 4-year median for Exchange Rate Effect is -$20500.0 (2024), against an average of -$49300.0.
- Across the five-year window, Exchange Rate Effect surged 262.07% in 2024 and tumbled 837.5% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at -$87000.0 in 2023, then jumped by 262.07% to $141000.0 in 2024, then slumped by 92.2% to $11000.0 in 2025, then slumped by 2927.27% to -$311000.0 in 2026.
- Per Business Quant, the three latest ZBIO Exchange Rate Effect figures stand at -$311000.0 (Q1 2026), $11000.0 (Q4 2025), and $25000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zenas BioPharma | 1.72 Bn | 1.72 Bn | - | -311,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -311,000.00 |
| Mar 31, 2026 | -311,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Jun 30, 2025 | -236,000.00 |
| Jun 30, 2025 | -236,000.00 |
| Mar 31, 2025 | -52,000.00 |
| Mar 31, 2025 | -52,000.00 |
| Dec 31, 2024 | 141,000.00 |
| Dec 31, 2024 | 141,000.00 |
| Sep 30, 2024 | -52,000.00 |
| Sep 30, 2024 | -52,000.00 |
| Jun 30, 2024 | 32,000.00 |
| Jun 30, 2024 | 32,000.00 |
| Mar 31, 2024 | 36,000.00 |
| Mar 31, 2024 | 36,000.00 |
| Dec 31, 2023 | -87,000.00 |
| Dec 31, 2023 | -87,000.00 |